Nurix Therapeutics, Inc. (NRIX)
15.48
-0.89
(-5.44%)
USD |
NASDAQ |
Jun 03, 16:00
15.55
+0.07
(+0.45%)
After-Hours: 19:59
Nurix Therapeutics Market Cap : 1.601B for June 3, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ultragenyx Pharmaceutical, Inc. | 2.196B |
| Alpha Cognition, Inc. | 132.39M |
| ACADIA Pharmaceuticals, Inc. | 3.666B |
| Alnylam Pharmaceuticals, Inc. | 39.04B |
| Anika Therapeutics, Inc. | 192.47M |
Market Cap Related Metrics
| PS Ratio | 20.12 |
| PEG Ratio | -0.391 |
| Price to Book Value | 3.328 |
| Price | 15.48 |
| Earnings Yield | -20.41% |
| PEGY Ratio | -0.391 |